Market Research Logo

Global Ablation Technologies Market - Segmented by Technology and Geography - Growth, Trends, and Forecast (2018 - 2023)

Global Ablation Technologies Market - Segmented by Technology and Geography - Growth, Trends, and Forecast (2018 - 2023)

The ablation technologies market is expected to register a CAGR of 10.7%, during the forecast period. Rising incidence of cancer and prevalence of cardiovascular diseases are the major factors driving the growth of this market. In addition, increasing number of ablation procedures, hospitals, surgical, and ablation centers and emergence of next-generation ablation products and technologies are further aiding to the growth prospects of this market. However, the use of refurbished devices in developing countries and healthcare cost-containment measures taken in a number of developed countries can hinder the growth of this market.

Rising Incidence of Cancer

According to WHO, cancer is one of the leading causes of morbidity and mortality worldwide and approximately 14 million people suffered from cancer worldwide in 2012. Globally, every one in six deaths is due to cancer. The number of new cases is expected to rise by about 70% over the next two decades; globally, it accounted for 8.8 million deaths in 2015. Cancer accounts for 13% deaths worldwide. Early detection of cancer is gaining pace and ablation technology is highly effective in the surgery for minor cancers therefore it will fuel the growth of this market. This, along with other factors, like emergence of next-generation ablation products and technology and growing prevalence of cardiovascular diseases will act as a driver for the ablation technology market.

Used Only for Minor Surgeries

The major factor hindering the growth of tumor ablation market is that tumor ablation can only be used for minor surgeries, like small size of tumors. In general, for cancers of about 3 cm or less, which are accessible percutaneous, can be treated with tumor ablation completely. To completely remove a cancer by tumor ablation, it should be accessible and of appropriate size. Other cancers are difficult to kill using this method, therefore limiting its applications. The fact that the cancer is not detected early in most of the cases hinders the market growth of tumor ablation. Since, early detection of cancer is necessary to perform tumor ablation before the tumor grows more than 3 cm, limits the possibility of completely killing the cancer. This, along with healthcare cost-containment, measures and unfavorable regulatory scenario will act as a restraining factor for the growth of ablation technology market.

Ablation Technology Market to Grow Substantially in North America

The United States has the largest installed base of ablation systems in the world. The large installed base is mainly due to the high standards of healthcare infrastructure in the country, easy availability of sophisticated technology and increasing government funding on cancer research. The growing investments of many key players of this market have grown significantly. In addition, the focus on the development of products with innovative features and greater effectiveness has increased in recent times. Also, in Europe and APAC, will show promising growth in the forecasted years.

Key Developments in the Market

  • October 2017 - Acutus Medical has announced that the US Food and Drug Administration (FDA) cleared the AcQMap high resolution imaging and mapping system as well as the AcQMap 3D imaging and mapping catheter this system will enable [practitioners] to rapidly map and re-map in order to visualise changes throughout the ablation procedure

Reasons to Purchase this Report
  • Current and future Ablation Technologies Market outlook in the developed and emerging markets
  • Analysis of various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3 months analyst support, along with the Market Estimate sheet (in Excel)
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Emergence of Next-generation Ablation Products and Technology
6.1.2 Rising Incidence of Cancer
6.1.3 Growing Prevalence of Cardiovascular Diseases
6.2 Market Restraints
6.2.1 Healthcare Cost-containment Measures
6.2.2 Used Only for Minor Surgeries
6.2.3 Unfavorable Regulatory Scenario
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Technology
7.1.1 Radiofrequency Ablators Temperature-Controlled Radiofrequency Ablators Fluid-Cooled Radiofrequency Ablators
7.1.2 Laser/Light Ablators Excimer Laser Ablators Cold Laser Ablators
7.1.3 Ultrasound Ablators Ultrasonic Surgical Ablation Systems High-Intensity Focused Ultrasound (HIFU) Ablators Extracorporeal Shockwave Lithotripsy (ESWL) Systems Magnetic Resonance-guided Focused Ultrasound (MRGFUS) Ablators
7.1.4 Electrical Ablators Argon Plasma/Beam Coagulators Irreversible Electroporation Ablators
7.1.5 Cryoablation Devices Tissue Contact Probes Tissue Spray Probes Epidermal and Subcutaneous Cryoablation Devices
7.1.6 Microwave Ablators Microwave Thermotherapy Devices
7.1.7 Hydrothermal Ablators Endometrial Hydrothermal Balloon Ablation Devices
7.2 By Geography
7.2.1 North America United States Canada Mexico
7.2.2 Europe France Germany United Kingdom Italy Spain Rest of Europe
7.2.3 Asia-Pacific China Japan India Australia & New Zealand South Korea Rest of Asia-Pacific
7.2.4 Middle East & Africa GCC South Africa Rest of the Middle East & Africa
7.2.5 South America Brazil Argentina Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Angiodynamics, Inc.
9.2 Atricure, Inc.
9.3 Biosense Webster, Inc. (A Subsidiary of Johnson & Johnson Inc.)
9.4 Boston Scientific Corporation
9.5 Conmed Corporation
9.6 Galil Medical Inc. (Acquired By BTG International Ltd.)
9.7 Medtronic PLC
9.8 Olympus Corporation
9.9 Smith & Nephew
9.10 St. Jude Medical, Inc.
9.11 List Not Exhaustive
10. Future of the Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report